CompletedPhase 1NCT03023319

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Studying Pleural mesothelioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nagla Abdel Karim
Principal Investigator
Nagla Karim, MD
Augusta University Georgia Cancer Center
Intervention
Bosutinib(drug)
Enrollment
6 enrolled
Eligibility
18 years · All sexes
Timeline
2019 – 2022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03023319 on ClinicalTrials.gov

Other trials for Pleural mesothelioma

Additional recruiting or active studies for the same condition.

See all trials for Pleural mesothelioma →

← Back to all trials